 鲜花( 0)  鸡蛋( 0)
|

楼主 |
发表于 2014-7-23 10:51
|
显示全部楼层
本帖最后由 柚子 于 2014-7-23 12:04 编辑 5 ~6 z. Y/ i" C
& D3 ~! z& g, B4 r
: O" ?, m: f$ p: t讲国语
+ [$ t* S9 {( k" {( W. T- i, r% K v
+ c. }* [" {+ Y. [https://www.merchantlaw.com/lawyers/38/Wei+Wu/1
! y1 s2 x# H1 \) t. J; U0 y* T( ^2 Z5 M. _* I0 v
; |4 r3 P* s# b& i; [Wei Wu
6 W) I ~ Z" z' K
5 q6 y( Z5 W/ P% WBack to Calgary lawyers
4 z7 i% C& i. ?1 W * y; t# f7 N3 u+ E
Areas of Practice [执业领域]% H0 C9 V1 D3 J4 _& z$ H3 \
· Business Law [商法]2 G% Q1 f' j+ F7 }) u7 s
· Class Action [集体诉讼]1 D# h% \( m# L4 M3 y4 S8 k* j+ p
· Contract Law [合同法]( o" H" x& l" p3 W; X
· Criminal Law [刑法]
7 Q( I& M0 |( v4 |$ r4 G$ Y! ^· Family Law [家庭法]% D: m$ y% e8 y
· Immigration Law [移民法]
6 B) Y: J6 e, e& \, {/ P+ n· Intellectual Property Law [知识产权法]; k; X# l; {+ U- u9 W4 }2 X1 F3 _
· International Law (commercial, trade) [国际贸易]' M2 ^6 O" u" y0 h
· Personal Injury [人身伤害]% _4 Z$ ]* Y J8 Q. c
· Real Estate [房产生意买卖过户]
* d7 Y# i: N ~· Tort Law [侵权法] U+ B& T( f% n# Y' S9 _
· Wills & Estates [遗嘱和公证]: L+ R) E4 F/ r; u+ B0 Q: U+ X, h
0 J7 h* k& c& X4 i: A1 p2 YProfessional Activities [专业活动]( N" K( G; A+ L5 u9 q
· Successfully appeared in the Provincial Court, Court of Queen's Bench, Court of Appeal, and Federal Court.
4 Y8 R" \( {4 C( I# I0 {% p1 G[成功代理众多客户出席在省法庭, 女王法庭,上诉法庭, 联邦法庭的庭审和辩护]- D0 w4 Y- ^# e9 ]3 O
· Successfully settled compensations for personal injury and other cases: h1 R4 z, K& C7 V
· Successfully gained satisfactory amount of compensation for clients
. Q: n9 p+ V( U2 R3 [9 h! ?+ \[成功代理众多人身伤害索赔案及其它民事索赔案,为客户争得满意的赔偿金额]9 M$ \& ]! O) u+ \0 S5 E9 Z
· Successfully obtained commutation sentence or pardons for clients whose criminal records have been cleared.4 K$ q0 x% ]- U7 N" W; k/ t9 K
[成功为众多刑事案件客户作无罪/或减刑辩护]
/ Z$ y- A+ F7 | D· Successfully won a number of Appeals at the IAD
* P8 V( W1 _# W, r7 x[成功为众多移民被拒客户打赢移民上诉]/ f+ U" W2 ^8 i' ` }
· Working on a broad range of cases, such as pharmaceutical and medical product related class proceedings (ie: Vioxx, Paxil, Zyprexa, Aranesp, Avandia, etc)
. h$ p" b/ B: G9 K6 k[主理众多的影响广大的药物伤害团体诉讼案(Vioxx, Paxil, Zyprexa, Aranesp, Avandia等)]
9 J' c4 u9 f3 \0 X% d 9 |5 l4 n0 y9 W/ `% E& x9 q0 L: q/ a
Background [专业背景]1 _% {6 u' N" D7 B6 r
· J.D., University of Saskatchewan, 2006
( w: n7 B- C$ X- E! M. W7 L! c[现在,加拿大默诚特法律集团]# [( A( p( x' c
· Research Assistant/Technical Officer, Plant Biotechnology Institute, National Research Council of Canada (PBPNRC), 2000-2003
! C: D! w0 e% L7 @/ c9 C( t2 `7 T* P[加拿大国家科学院生物植物研究所助理研究员]
; P6 |- Q( \3 a5 O· Postdoctoral Associate, Bio-organic Chemistry, UBC, Canada, 1997-1999! X; ?. N: N, N
[加拿大大不列颠哥伦比亚大学博士后(有机化学)]- B2 j$ _" T* J8 D& V/ _
· Ph.D. Pharmaceutical Sciences, Nagoya City University, Japan, 19962 n$ l0 C" ]& c
[日本名古屋市立大学药学博士]
: P: g- M: o1 t" [· Sasagawa Memorial Foundation (Scholarship), Japan, 1993% [' g; F& }) R! q
[日本笹川纪念基金会奖学金获得者]
! S, @3 P( _# q2 x# b0 U G7 n% P· Assistant Professor &. Lecturer, Dept. of Pharmaceutical Analysis, Anhui College of Traditional Chinese Medicine, China, 1985-1993
, Y3 S! p: h4 u0 t8 \[中国安徽中医学院药物分析专业助理教授]
1 u( Z& p. b1 W2 [$ w; }* V· B.Sc. Pharmacy, Xian Medical University, China, 1985
/ Y( ~ }$ W+ J+ ]. l* n: d[中国西安医科大学药学系]
( l% F# X' k- T( M y3 K! V: n8 [0 {/ s5 K
Bar Admissions [律师资格]+ V% Y; H" J6 v1 s& j$ X- n% u: k
· Called to the Bar, Saskatchewan, 2007 [取得萨斯卡川省律师执照]) A1 S- o8 V3 Q' k- l! |7 ^$ j
+ Y) G- {! J3 }8 t; i1 X3 |
Memberships [专业协会成员资格]
, q2 C D1 G+ L7 @. C· Law Society of Saskatchewan [加拿大萨斯卡川省律师协会会员]3 F/ m) m3 U& J+ Q' W
· (past member) Pharmaceutical Society of Japan [日本药学协会前会员]/ \. y. X7 G, P9 W
5 @9 n& \' @: j; j9 p2 }Languages [语言]
# `. R; Q4 p9 ^5 a· English [英语]3 y+ e6 i2 U" q4 o
· Mandarin [国语]
$ v$ c" y: i: v· Japanese [日语]* l1 O& \1 m) o
2 M% f4 g4 |$ z t. p6 @7 P7 fContact [联系信息]
F, X$ K0 e# s4 O4 c3 @# C g403-237-7777 [电话]
8 ?( C" Q( A' j+ P8 |: W5 e306-359-7777 [电话]
, Z( O# ]( O3 K6 H& X. j& |; E2 m1 l1-888-567-7777 [加国免费热线]
4 G S) D3 o7 a$ a1 uweiwu@merchantlaw.com [电邮]
* Y$ Z, u* p. @& i, \wuwei16@hotmail.com1 M5 p' k/ s, p0 j9 t! {- P
www.merchantlaw.com [网址]
! v5 B' i, A. L3 e |
|